Wave of Biotech Drugs Set to Flood the Psoriasis Market: Amevive Rides the Crest

Author：  

Publisher： Adis International

ISSN： 1537-1328

Source： Pharmaceutical Innovation, Vol.11, Iss.6, 2002-10, pp. : 16-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on biotech drugs for psoriasis

By  

Inpharma, Vol. 1, Iss. 1297, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Amevive First to Enter Psoriasis Market—Competitor Products Closing In Quickly

By  

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 2, 2003-01 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Biotech agents for psoriasis show promise

By  

Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Hospital spending on biotech drugs shows steady rise

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies

By  

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 661-691

Bentham Science Publishers

Access to resources Recommend Favorite